Faculty profile
Peter Libby
Back to facultyResearch
Read how they describe their research on their Université Laval profile.
Latest papers
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
The New England journal of medicine · 2019
Latest funding
- $225,000
The influence of stromal bone marrow cells on hematopoiesis and inflammatory leukocyte supply in atherosclerosis
CIHR · 2024 · Supervisor
1 publications.
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber SZ, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ, CIRT Investigators
The influence of stromal bone marrow cells on hematopoiesis and inflammatory leukocyte supply in atherosclerosis
Principal investigators: Ting, Kenneth K
Keywords: Atherosclerosis; Blood Stem Cells; Bone Marrow; Hyperlipidemia; Leukocytes; Lipid Metabolism; Monocytes; Single Cell Rna Sequencing
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 27, 2026 from the university directory, publication records and public research funding records.